Trial · NCT03496207
Adverse events2,023
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,023
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Base Study: Placebo | 2 | 32 | 3 |
| other | Anaemia | Blood and lymphatic system disorders | Base Study: Sotatercept 0.3 mg/kg | 1 | 32 | 2 |
| other | Anaemia | Blood and lymphatic system disorders | Base Study: Sotatercept 0.7 mg/kg | 2 | 42 | 2 |
| other | Anaemia | Blood and lymphatic system disorders | Extension Period: Placebo→Sotatercept 0.3 mg/kg | 0 | 15 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | Extension Period: Placebo→Sotatercept 0.7 mg/kg | 2 | 15 | 2 |
| other | Anaemia | Blood and lymphatic system disorders | Extension Period: Sotatercept 0.3 mg/kg | 8 | 31 | 13 |
| other | Anaemia | Blood and lymphatic system disorders | Extension Period: Sotatercept 0.7 mg/kg | 1 | 36 | 2 |
| other | Blood loss anaemia | Blood and lymphatic system disorders | Base Study: Placebo | 0 | 32 | 0 |
| other | Blood loss anaemia | Blood and lymphatic system disorders | Base Study: Sotatercept 0.3 mg/kg | 0 | 32 | 0 |
| other | Blood loss anaemia | Blood and lymphatic system disorders | Base Study: Sotatercept 0.7 mg/kg | 0 | 42 | 0 |
| other | Blood loss anaemia | Blood and lymphatic system disorders | Extension Period: Placebo→Sotatercept 0.3 mg/kg | 0 | 15 | 0 |
| other | Blood loss anaemia | Blood and lymphatic system disorders | Extension Period: Placebo→Sotatercept 0.7 mg/kg | 1 | 15 | 1 |
| other | Blood loss anaemia | Blood and lymphatic system disorders | Extension Period: Sotatercept 0.3 mg/kg | 0 | 31 | 0 |
| other | Blood loss anaemia | Blood and lymphatic system disorders | Extension Period: Sotatercept 0.7 mg/kg | 0 | 36 | 0 |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Base Study: Placebo | 2 | 32 | 2 |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Base Study: Sotatercept 0.3 mg/kg | 1 | 32 | 1 |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Base Study: Sotatercept 0.7 mg/kg | 0 | 42 | 0 |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Extension Period: Placebo→Sotatercept 0.3 mg/kg | 0 | 15 | 0 |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Extension Period: Placebo→Sotatercept 0.7 mg/kg | 4 | 15 | 5 |
| other | Iron deficiency anaemia | Blood and lymphatic system disorders | Extension Period: Sotatercept 0.3 mg/kg | 1 | 31 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03496207/events